This apparent randomness derives, in part from these phenomena having their origin at a molecular level, with the recognition of minor histocompatibility antigens (mHA) and tumor specific antigens (TSA) bound to HLA molecules on the antigen presenting cells (APC), by unique T cell receptors (TCR) on T cell clones. The gene discussed is MYH9; the disease is neoplasm.